Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integromics is a bioinformatics company that provides advanced data analysis and management solutions for the life sciences industry. Founded in 2002 as a spin-off from the Spanish National Center for Biotechnology (CNB-CSIC), the company specializes in genomics and proteomics data interpretation. Its product portfolio includes SeqSolve for next-generation sequencing (NGS) analysis, RealTime StatMiner for qPCR data, and OmicsOffice, which integrates with TIBCO Spotfire to provide comprehensive omics data visualization. These platforms are designed to help researchers in pharmaceutical, academic, and clinical settings extract biological insights from complex "omics" datasets. The company was acquired by PerkinElmer in 2013 and its technologies are now part of the Revvity ecosystem following PerkinElmer's corporate rebranding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integromics.